HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade
Frontiers in Immunology · 2026
DOI: 10.3389/fimmu.2026.2018159 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Zhen Wei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Equipment, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, C…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, High-Intensity Focused Ultrasound Ablation. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, State Key Laboratory of Ultrasound in Medicine and Engineering.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) usually develops within chronically inflamed and fibrotic liver tissue. This background creates an organ-specific immune niche in which macrophages, sinusoidal endothelial cells, activated stellate cells and extracellular matrix constrain T-cell access and sustain checkpoint-dependent tolerance. Spatial mapping places VEGFA-positive macrophages near CD34-positive endothelium and predicts VEGFA signaling, defining a candidate vascular barrier to PD-1/PD-L1 blockade. High-intensity focused ultrasound (HIFU) can disrupt tumor tissue and may alter this niche. Mechanical HIFU can fragment tumor tissue, release immunogenic material and activate dendritic cells, while focused ultrasound approaches can repolarize macrophages, increase T-cell infiltration and induce adaptive PD-L1 expression. These preclinical effects motivate combination with checkpoint inhibition, while direct niche remodeling in fibrotic HCC remains to be tested. This mini review examines how HIFU may remodel the fibrotic perivascular myeloid niche, why the resulting inflammatory window may sensitize HCC to PD-1/PD-L1 blockade, and which spatial and temporal biomarkers are required for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Equipment, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
- Sichuan Clinical Research Center for Radiation and Therapy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
- Department of Oncology, Mianyang Central Hospital,School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
Förderung
- Natural Science Foundation of China
- State Key Laboratory of Ultrasound in Medicine and Engineering
Zitieren
APA
Wei, Z., & Liao, Y. (2026). HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.2018159
Vancouver
Wei Z, Liao Y. HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.2018159
BibTeX
@article{Wei2026,
author = {Wei, Zhen and Liao, Yao},
title = {HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.2018159}
}
EUVIMED